Advertisement
Home »

A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy.

May 22, 2023

ABOUT THE EXPERTS

  • Steven T Szabo

    Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA. Electronic address: steven.szabo@sunovion.com.

    Seth C Hopkins

    Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA. Electronic address: seth.hopkins@sunovion.com.

    Robert Lew

    Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA. Electronic address: robert.lew@sunovion.com.

    Antony Loebel

    Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA. Electronic address: antony.loebel@sunovion.com.

    Thomas Roth

    Sleep Disorders and Research Center, Henry Ford Hospital, 2799 West Grand Boulevard Detroit, MI, 48202, USA. Electronic address: troth1@hfhs.org.

    Kenneth S Koblan

    Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA. Electronic address: kenneth.koblan@sunovion.com.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement